Ascentage Pharma Group International
AAPG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023311
No open-market purchases or sales by Ascentage Pharma Group International insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $263.5K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Ascentage Pharma Group International changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 7 | 8 | +1 |
| Shares | 30.2K | 15.0K | −15.2K (−50.4%) |
| Value | $721.7K | $263.5K | −$458.2K (−63.5%) |
New holders (3)
Institutions that held Ascentage Pharma Group International at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wells Fargo & Company | 200 | $3.51K | 0.00% |
| BlackRock, Inc. | 6 | $105 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $18 | 0.00% |
Sold out (2)
Institutions that held Ascentage Pharma Group International at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| XY Capital Ltd | 13,014 | $310.6K |
| Tower Research Capital LLC (TRC) | 518 | $12.4K |